3-hydroxypregn-4-en-20-one has been researched along with flumazenil in 1 studies
| Studies (3-hydroxypregn-4-en-20-one) | Trials (3-hydroxypregn-4-en-20-one) | Recent Studies (post-2010) (3-hydroxypregn-4-en-20-one) | Studies (flumazenil) | Trials (flumazenil) | Recent Studies (post-2010) (flumazenil) |
|---|---|---|---|---|---|
| 29 | 0 | 2 | 4,673 | 426 | 981 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kavaliers, M; Wiebe, JP | 1 |
1 other study(ies) available for 3-hydroxypregn-4-en-20-one and flumazenil
| Article | Year |
|---|---|
Analgesic effects of the putative FSH-suppressing gonadal steroid, 3 alpha-hydroxy-4-pregnen-20-one: possible modes of action.
Topics: 20-alpha-Dihydroprogesterone; Analgesia; Analgesics; Animals; Bicuculline; Calcium Channel Blockers; Cerebral Ventricles; Flumazenil; Follicle Stimulating Hormone; Injections, Intraventricular; Male; Mice; Naloxone; Progesterone; Reference Values | 1988 |